As Trump’s second term nears, Republican support for NIH is at a low point By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research

USPSTF doesn’t lean right or left—it’s about data, not politics

Multiple components of the healthcare and public health systems are currently under scrutiny. One of them is reportedly the U.S. Preventive Services Task Force (USPSTF: “Task Force”), established in 1984 and managed by the Agency for Healthcare Research and Quality. It was created to maintain an ongoing evaluation of disease prevention and screening interventions that...

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

NCI announced that the paylines for R01 grants for established and new investigators are expected to drop to the 4th percentile—a historic low for the institute.

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

A report from the nonpartisan Congressional Budget Office said that proposed cuts at NIH could lead to a decrease in the number of new drugs that come to market in the next three decades.

Supreme Court lifts lower-court freeze on RIFs

The U.S. Supreme Court has temporarily lifted a lower court’s freeze on the Trump administration’s reductions in force, or RIFs, freeing the government to continue their large-scale restructuring of the federal government.

Medical, cancer groups respond to Trump’s “Big Beautiful Bill” becoming law

The United States House of Representatives July 3 voted to pass H.R.1, also known as the “One Big Beautiful Bill Act.” President Trump signed the bill into law July 4 (The Cancer Letter, July 3, 2025).

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

June 27, 2025

Vol.51 No.25

By Claire Marie Porter

As Trump’s second term nears, Republican support for NIH is at a low point

By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research

YOU MAY BE INTERESTED IN

USPSTF doesn’t lean right or left—it’s about data, not politics

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

Supreme Court lifts lower-court freeze on RIFs

Medical, cancer groups respond to Trump’s “Big Beautiful Bill” becoming law

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”

Renew today!

Subscriber content

Never miss an issue!

Login

As Trump’s second term nears, Republican support for NIH is at a low point

By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research

YOU MAY BE INTERESTED IN

USPSTF doesn’t lean right or left—it’s about data, not politics

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

Supreme Court lifts lower-court freeze on RIFs

Medical, cancer groups respond to Trump’s “Big Beautiful Bill” becoming law

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policiesRep. Lori Trahan: “People are going to die”

Never miss an issue!

Login

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”